-
Featured Authors
-
Archives
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: Brazil
IP in Latin America: Growing Recognition of the Importance of IP to Innovation
The Inter-American Dialogue’s daily Latin America Advisor recently asked the question “How seriously do Latin American countries protect IP rights?” The editors asked various stakeholders about the U.S. Trade Representative’s Special 301 Report and its evaluation of Latin America’s protection of IP rights. BIO’s Director for International Affairs, Meredith Fensom, commented on the growth of the innovative biotechnology sectors in Latin America and the critical role intellectual property plays. ”The presence of more than 60 Read More >
Brazil Patent Policy: At a Crossroads
The Government of Brazil approaches the patent policy crossroads with two ministries wanting to move in opposite directions. In the last few months, both the Brazilian Patent Office (INPI) and the Brazilian Regulatory Authority (ANVISA) issued proposed rules concerning patents and are sifting through public comments to determine how they will deal with biotech patents. A quirk in Brazilian law requires that the health regulatory authority (ANVISA) must provide “prior consent” on the grant of a pharmaceutical patent. Traditionally, Read More >
BIO Travels to Brazil to Support the Ecosystem of Innovation
Government policies that support innovation are critical as the biotechnology industry seeks to develop innovative healthcare, agricultural, industrial and environmental biotechnology products and provide them to people all around the world. Innovation requires not only scientific research and commercial expertise, but also supportive and dynamic governments that help facilitate long-term growth of the industry. Brazil has recognized the value of innovation in maintaining a robust, diversified economy that can compete in the 21st century, and declared Read More >
Amgen Hosts Science without Borders Students
This year, Amgen is hosting six Science without Borders undergraduate interns at its Thousand Oaks, California headquarters. The Science without Borders program is a Brazilian scholarship program that seeks to train 101,000 students and researchers in top universities worldwide in science, technology, engineering and math (STEM) fields by 2014. The Amgen internship program will provide students with a unique opportunity to experience the biotechnology industry. There was considerable interest in the programme with a high Read More >
Brazil Reaches Beyond Borders to Strengthen STEM Education
The Brazilian government has set an aggressive goal: To train 101,000 Brazilian students and researchers in top universities worldwide in science, technology, engineering and math (STEM) fields by 2014. Launched in 2011, the Science without Borders program is a Brazilian scholarship program, primarily funded by the government of Brazil, that seeks to strengthen and expand science and technology initiatives, innovation and competitiveness through international mobility of undergraduate and graduate students and researchers. Brazilian students and Read More >
